Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

PURPOSE: Men with high-risk features (extraprostatic extension or high Gleason grade) face a high risk of prostate cancer recurrence after radical prostatectomy. Clinical trials of adjuvant systemic therapy for such patients have been limited. PATIENTS AND METHODS: The SWOG (Southwest Oncology Group...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dorff, Tanya B., Flaig, Thomas W., Tangen, Catherine M., Hussain, Maha H.A., Swanson, Gregory P., Wood, David P., Sakr, Wael A., Dawson, Nancy A., Haas, Naomi B., Crawford, E. David, Vogelzang, Nicholas J., Thompson, Ian M., Glode, L. Michael
Format:	Artigo
Language:	Inglês
Published:	American Society of Clinical Oncology 2011
Subjects:	Original Reports
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3107759/ https://ncbi.nlm.nih.gov/pubmed/21502546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.2776
Tags:	Add Tag No Tags, Be the first to tag this record!

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Similar Items